2023 annual financial data
Pacific Biosciences of California 2023 Operating cash flow margin
Direct answer
Operating cash flow margin was -132.93%.
Operating income was -334,467,000 USD and net income was -306,735,000 USD.
Operating cash flow was -266,548,000 USD.
Get free Pacific Biosciences of California email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 200,521,000 USD
- Operating income
- -334,467,000 USD
- Net income
- -306,735,000 USD
- Operating cash flow
- -266,548,000 USD